Lymphomatoid papulosis: remission following intravenously administered acyclovir

Area of Science:

• Dermatology
• Oncology
• Virology

Background:

• Lymphomatoid papulosis is a rare skin condition often associated with hematologic malignancies.
• Hodgkin's disease is a type of lymphoma that affects the immune system.
• The etiology of lymphomatoid papulosis and its association with viral infections are not fully understood.

Observation:

• A 54-year-old male patient diagnosed with Hodgkin's disease presented with lymphomatoid papulosis.
• Intravenous administration of acyclovir resulted in immediate and complete clearing of the patient's skin lesions.
• The patient experienced multiple relapses of the skin eruption, with each relapse responding completely to subsequent acyclovir treatment.

Findings:

• Acyclovir demonstrated a striking therapeutic effect on lymphomatoid papulosis.
• The observed efficacy of acyclovir in this case aligns with previous reports of its effectiveness in mycosis fungoides and chronic generalized lymphadenopathy.
• The precise mechanism of action of acyclovir in these T-cell mediated disorders remains unknown.

Implications:

• Acyclovir's efficacy suggests a potential role in managing T-cell mediated dermatological conditions, including lymphomatoid papulosis.
• The findings prompt further investigation into acyclovir's specific effects on T lymphocytes or its potential antiviral activity in these diseases.
• This case highlights the need for research into the viral etiology or T-cell interactions in lymphomatoid papulosis and related disorders.